Advertisement
Home Blog Page 3098

November 2016 Briefing – Gastroenterology

0
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for November 2016. This roundup includes the latest...

November 2016 Briefing – Family Practice

0
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for November 2016. This roundup includes the...

November 2016 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2016. This roundup includes...

November 2016 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for November 2016. This roundup includes the latest...

November 2016 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for November 2016. This roundup includes the latest...

November 2016 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for November 2016. This roundup includes the latest...
Healthier diets may be a factor in the ongoing decline in cholesterol levels for Americans

Levels of Total, LDL Cholesterol Continue to Fall in the U.S.

0
Eliminating trans fats from the U.S. diet may be one factor in this healthy trend
The first case of an infant who developed glaucoma after being exposed to the Zika virus while in the womb has been reported by an international team of researchers. The case was reported online Nov. 30 in Ophthalmology.

Infant Diagnosed With First Case of Zika-Related Glaucoma

0
Brazilian baby developed condition after being exposed to virus in womb
Although there was a significant increase in the use of syringe services programs -- more commonly known as needle exchange programs -- across the United States over the past decade

CDC: Needle Exchange Program Usage Up Significantly

0
Yet, many drug users still share needles sometimes, researchers find
The experimental drug CB-839 shows promise in treating kidney cancer

Drug Shows Promise in Clear Cell, Papillary Renal Cell Cancer

0
93 percent had tumor growth controlled for median of more than eight months, researchers report